Frontiers in Endocrinology (Sep 2023)

Prediction of postoperative health-related quality of life among patients with metastatic spinal cord compression secondary to lung cancer

  • Yufang Fu,
  • Weiqing Shi,
  • Jing Zhao,
  • Jing Zhao,
  • Xuyong Cao,
  • Yuncen Cao,
  • Mingxing Lei,
  • Mingxing Lei,
  • Mingxing Lei,
  • Xiuyun Su,
  • Qiu Cui,
  • Qiu Cui,
  • Qiu Cui,
  • Yaosheng Liu,
  • Yaosheng Liu,
  • Yaosheng Liu

DOI
https://doi.org/10.3389/fendo.2023.1206840
Journal volume & issue
Vol. 14

Abstract

Read online

BackgroundHealth-related quality of life (HRQoL) is a critical aspect of overall well-being for patients with lung cancer, particularly those with metastatic spinal cord compression (MSCC). However, there is currently a lack of universal evaluation of HRQoL in this specific patient population. The aim of this study was to develop a nomogram that can accurately predict HRQoL outcomes in patients with lung cancer-related MSCC.MethodsA total of 119 patients diagnosed with MSCC secondary to lung cancer were prospectively collected for analysis in the study. The least absolute shrinkage and selection operator (LASSO) regression analysis, along with 10-fold cross-validation, was employed to select the most significant variables for inclusion in the nomogram. Discriminative and calibration abilities were assessed using the concordance index (C-index), discrimination slope, calibration plots, and goodness-of-fit tests. Net reclassification index (NRI) and integrated discrimination improvement (IDI) analyses were conducted to compare the nomogram’s performance with and without the consideration of comorbidities.ResultsFour variables were selected to construct the final nomogram, including the Eastern Cooperative Oncology Group (ECOG) score, targeted therapy, anxiety scale, and number of comorbidities. The C-index was 0.87, with a discrimination slope of 0.47, indicating a favorable discriminative ability. Calibration plots and goodness-of-fit tests revealed a high level of consistency between the predicted and observed probabilities of poor HRQoL. The NRI (0.404, 95% CI: 0.074–0.734, p = 0.016) and the IDI (0.035, 95% CI: 0.004–0.066, p = 0.027) confirmed the superior performance of the nomogram with the consideration of comorbidities.ConclusionsThis study develops a prediction nomogram that can assist clinicians in evaluating postoperative HRQoL in patients with lung cancer-related MSCC. This nomogram provides a valuable tool for risk stratification and personalized treatment planning in this specific patient population.

Keywords